Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ABCG5 CL E G H | 64240 | 13886 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 67 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ABCG8 CL E G H | 64241 | 13887 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 76 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ABHD5 CL E G H | 51099 | 21396 | OMIM:275630 | Chanarin-Dorfman syndrome | | | | 90 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ABHD5 CL E G H | 51099 | 21396 | ORPHA:98907 | Neutral lipid storage disease with ichthyosis | | | | 90 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | | | | 98 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACAD9 CL E G H | 28976 | 21497 | OMIM:611126 | Mitochondrial complex I deficiency due to acad9 deficiency | | | | 98 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | | | | 197 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ACOX1 CL E G H | 51 | 119 | OMIM:264470 | Peroxisomal acyl-coa oxidase deficiency | | | | 120 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | | | | 26 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 85 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | AGPAT2 CL E G H | 10555 | 325 | OMIM:608594 | Lipodystrophy, congenital generalized, type 1 | | | | 85 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | AKT2 CL E G H | 208 | 392 | ORPHA:79085 | AKT2-related familial partial lipodystrophy | | | | 12 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | | | | 73 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | | | | 404 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | | | | 404 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | APOB CL E G H | 338 | 603 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 356 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | | | | 39 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ATP6AP1 CL E G H | 537 | 868 | OMIM:300972 | IMMUNODEFICIENCY 47; IMD47 | | | | 5 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ATP6AP2 CL E G H | 10159 | 18305 | OMIM:301045 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R | | | | 36 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | | | | 315 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BCS1L CL E G H | 617 | 1020 | ORPHA:53693 | GRACILE syndrome | | | | 72 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | | | | 72 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 105 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | | | | 105 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | | | | 105 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CARS2 CL E G H | 79587 | 25695 | OMIM:616672 | Combined oxidative phosphorylation deficiency 27 | | | | 35 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CASZ1 CL E G H | 54897 | 26002 | ORPHA:1606 | 1p36 deletion syndrome | | | | 3 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 11 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:612526 | Lipodystrophy, congenital generalized, type 3 | | | | 11 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 48 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CAVIN1 CL E G H | 284119 | 9688 | OMIM:613327 | Lipodystrophy, congenital generalized, type 4 | | | | 48 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CBS CL E G H | 875 | 1550 | OMIM:236200 | Homocystinuria due to cystathionine beta-synthase deficiency | | | | 242 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CEP19 CL E G H | 84984 | 28209 | OMIM:615703 | Morbid obesity and spermatogenic failure | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CIDEC CL E G H | 63924 | 24229 | ORPHA:435651 | CIDEC-related familial partial lipodystrophy | | | | 8 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CIDEC CL E G H | 63924 | 24229 | OMIM:615238 | Lipodystrophy, familial partial, type 5 | | | | 8 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CLPB CL E G H | 81570 | 30664 | ORPHA:445038 | 3-methylglutaconic aciduria type 7 | | | | 38 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | COX15 CL E G H | 1355 | 2263 | OMIM:615119 | Mitochondrial complex IV deficiency, nuclear type 6 | | | | 104 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CPT1A CL E G H | 1374 | 2328 | OMIM:255120 | Carnitine palmitoyltransferase I deficiency | | | | 99 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:600649 | Carnitine palmitoyltransferase II deficiency, infantile | | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | . | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CYP19A1 CL E G H | 1588 | 2594 | ORPHA:91 | Aromatase deficiency | | | | 60 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | | | | 11 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DDOST CL E G H | 1650 | 2728 | ORPHA:300536 | DDOST-CDG | | | | 62 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DEF6 CL E G H | 50619 | 2760 | OMIM:619573 | IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DGUOK CL E G H | 1716 | 2858 | OMIM:251880 | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | | | | 57 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DHCR7 CL E G H | 1717 | 2860 | OMIM:270400 | Smith-Lemli-Opitz syndrome | | | | 159 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DNAJC19 CL E G H | 131118 | 30528 | OMIM:610198 | 3-@methylglutaconic aciduria, type V | | | | 25 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DNAJC19 CL E G H | 131118 | 30528 | ORPHA:66634 | Dilated cardiomyopathy with ataxia | | | | 25 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DOCK2 CL E G H | 1794 | 2988 | OMIM:616433 | Immunodeficiency 40 | | | | 6 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | DPM1 CL E G H | 8813 | 3005 | ORPHA:79322 | DPM1-CDG | | | | 27 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | EARS2 CL E G H | 124454 | 29419 | OMIM:614924 | Combined oxidative phosphorylation deficiency 12 | | | | 80 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ETFA CL E G H | 2108 | 3481 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 37 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ETFB CL E G H | 2109 | 3482 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 27 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ETFDH CL E G H | 2110 | 3483 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 77 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | FARSA CL E G H | 2193 | 3592 | OMIM:619013 | RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | FARSB CL E G H | 10056 | 17800 | OMIM:613658 | Rajab interstitial lung disease with brain calcifications | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | | | | 64 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | GABRD CL E G H | 2563 | 4084 | ORPHA:1606 | 1p36 deletion syndrome | | | | 10 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | GPD1 CL E G H | 2819 | 4455 | OMIM:614480 | Hypertriglyceridemia, transient infantile | | | | 3 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HADH CL E G H | 3033 | 4799 | OMIM:231530 | 3-Hydroxyacyl-Coa dehydrogenase deficiency | | | | 41 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | HP:0040282 - Frequent | | | 35 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HNF1B CL E G H | 6928 | 11630 | ORPHA:93111 | HNF1B-related autosomal dominant tubulointerstitial kidney disease | | | | 90 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HNRNPA1 CL E G H | 3178 | 5031 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 31 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HNRNPA2B1 CL E G H | 3181 | 5033 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 5 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HSD17B4 CL E G H | 3295 | 5213 | OMIM:261515 | D-bifunctional protein deficiency | | | | 98 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1606 | 1p36 deletion syndrome | | | | 345 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | IARS1 CL E G H | 3376 | 5330 | ORPHA:541423 | Growth delay-intellectual disability-hepatopathy syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | IARS1 CL E G H | 3376 | 5330 | OMIM:617093 | Growth retardation, impaired intellectual development, hypotonia, and hepatopathy | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | IFIH1 CL E G H | 64135 | 18873 | OMIM:615846 | Aicardi-Goutieres syndrome 7 | | | | 28 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | KCNAB2 CL E G H | 8514 | 6229 | ORPHA:1606 | 1p36 deletion syndrome | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | KMT2B CL E G H | 9757 | 15840 | OMIM:619934 | | | | | 11 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LARS1 CL E G H | 51520 | 6512 | OMIM:615438 | Infantile liver failure syndrome 1 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LDLR CL E G H | 3949 | 6547 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 2157 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LDLRAP1 CL E G H | 26119 | 18640 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 73 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LIPA CL E G H | 3988 | 6617 | OMIM:278000 | Lysosomal acid lipase deficiency | | | | 73 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LIPE CL E G H | 3991 | 6621 | ORPHA:435660 | LIPE-related familial partial lipodystrophy | | | | 7 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LIPE CL E G H | 3991 | 6621 | OMIM:615980 | Lipodystrophy, familial partial, type 6 | | | | 7 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | | | | 645 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:280365 | Autosomal semi-dominant severe lipodystrophic laminopathy | | | | 645 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:2348 | Familial partial lipodystrophy, Dunnigan type | | | | 645 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:79084 | Familial partial lipodystrophy, Köbberling type | | | | 645 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNA CL E G H | 4000 | 6636 | OMIM:151660 | Lipodystrophy, familial partial, type 2 | | | | 645 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LMNB2 CL E G H | 84823 | 6638 | ORPHA:79087 | Acquired partial lipodystrophy | | | | 11 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | | | | 191 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | | | | 191 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LUZP1 CL E G H | 7798 | 14985 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MARS1 CL E G H | 4141 | 6898 | OMIM:615486 | Interstitial lung and liver disease | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | | | | 81 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MICOS13 CL E G H | 125988 | 33702 | OMIM:618329 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MMP23B CL E G H | 8510 | 7171 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MPV17 CL E G H | 4358 | 7224 | OMIM:256810 | Navajo neurohepatopathy | | | | 56 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MRPL3 CL E G H | 11222 | 10379 | OMIM:614582 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9 | | | | 13 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MRPL44 CL E G H | 65080 | 16650 | OMIM:615395 | Combined oxidative phosphorylation deficiency 16 | | | | 13 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MRPS7 CL E G H | 51081 | 14499 | OMIM:617872 | Combined oxidative phosphorylation deficiency 34 | | | | 12 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | | | | 81 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | MTX2 CL E G H | 10651 | 7506 | OMIM:619127 | MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NDUFAF1 CL E G H | 51103 | 18828 | OMIM:618234 | Mitochondrial complex I deficiency, nuclear type 11 | | | | 40 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NFS1 CL E G H | 9054 | 15910 | OMIM:619386 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52 | | | | 5 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NHLRC2 CL E G H | 374354 | 24731 | OMIM:618278 | Fibrosis, neurodegeneration, and cerebral angiomatosis | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NSMCE2 CL E G H | 286053 | 26513 | ORPHA:436182 | Microcephalic primordial dwarfism-insulin resistance syndrome | | | | 2 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PCK1 CL E G H | 5105 | 8724 | OMIM:261680 | Phosphoenolpyruvate carboxykinase deficiency, cytosolic | | | | 53 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PCK2 CL E G H | 5106 | 8725 | OMIM:261650 | Phosphoenolpyruvate carboxykinase 2, mitochondrial | | | | 6 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PCSK9 CL E G H | 255738 | 20001 | ORPHA:391665 | Homozygous familial hypercholesterolemia | | | | 178 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PDPN CL E G H | 10630 | 29602 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PGM1 CL E G H | 5236 | 8905 | OMIM:614921 | Congenital disorder of glycosylation, type It | | | | 58 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PHKA2 CL E G H | 5256 | 8926 | ORPHA:264580 | Glycogen storage disease due to liver phosphorylase kinase deficiency | | | | 54 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PHKG2 CL E G H | 5261 | 8931 | ORPHA:264580 | Glycogen storage disease due to liver phosphorylase kinase deficiency | | | | 48 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PIGA CL E G H | 5277 | 8957 | OMIM:300868 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | | | | 46 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PLIN1 CL E G H | 5346 | 9076 | OMIM:613877 | Lipodystrophy, familial partial, type 4 | | | | 19 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PLIN1 CL E G H | 5346 | 9076 | ORPHA:280356 | PLIN1-related familial partial lipodystrophy | | | | 19 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PMM2 CL E G H | 5373 | 9115 | OMIM:212065 | Congenital disorder of glycosylation, type Ia | | | | 150 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PNPLA2 CL E G H | 57104 | 30802 | OMIM:610717 | Neutral lipid storage disease with myopathy | | | | 65 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PNPLA2 CL E G H | 57104 | 30802 | ORPHA:98908 | Neutral lipid storage myopathy | | | | 65 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | POLD1 CL E G H | 5424 | 9175 | OMIM:615381 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | | | | 731 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | | | | 464 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 464 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 42 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | | | | 42 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | | | | 42 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PRDM16 CL E G H | 63976 | 14000 | ORPHA:1606 | 1p36 deletion syndrome | | | | 148 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PRKCZ CL E G H | 5590 | 9412 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | PTRH2 CL E G H | 51651 | 24265 | OMIM:616263 | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset | | | | 6 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | RERE CL E G H | 473 | 9965 | ORPHA:1606 | 1p36 deletion syndrome | | | | 16 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | RINT1 CL E G H | 60561 | 21876 | OMIM:618641 | INFANTILE LIVER FAILURE SYNDROME 3; ILFS3 | | | | 99 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | | | | 26 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | RNU7-1 CL E G H | 100147744 | 34033 | OMIM:619487 | AICARDI-GOUTIERES SYNDROME 9; AGS9 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 125 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SAR1B CL E G H | 51128 | 10535 | ORPHA:71 | Chylomicron retention disease | | | | 8 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SKI CL E G H | 6497 | 10896 | ORPHA:1606 | 1p36 deletion syndrome | | | | 150 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | | | | 82 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC25A13 CL E G H | 10165 | 10983 | OMIM:603471 | Citrullinemia, type II, adult-onset | | | | 82 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247598 | Neonatal intrahepatic cholestasis due to citrin deficiency | | | | 82 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC25A20 CL E G H | 788 | 1421 | OMIM:212138 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:619525 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw; CDG2W | | | | 110 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC40A1 CL E G H | 30061 | 10909 | ORPHA:139491 | Hemochromatosis type 4 | | | | 56 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SLC40A1 CL E G H | 30061 | 10909 | OMIM:606069 | Hemochromatosis, type 4 | | | | 56 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SPEN CL E G H | 23013 | 17575 | ORPHA:1606 | 1p36 deletion syndrome | | | | 4 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | | | | 60 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | 73 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TARS2 CL E G H | 80222 | 30740 | OMIM:615918 | Combined oxidative phosphorylation deficiency 21 | | | | 28 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TBX1 CL E G H | 6899 | 11592 | OMIM:188400 | Digeorge syndrome | | | | 32 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TFAM CL E G H | 7019 | 11741 | OMIM:617156 | Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TKFC CL E G H | 26007 | 24552 | OMIM:618805 | TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TMEM199 CL E G H | 147007 | 18085 | OMIM:616829 | Congenital disorder of glycosylation, type IIP | | | | 4 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TRAPPC11 CL E G H | 60684 | 25751 | OMIM:615356 | Muscular dystrophy, limb-girdle, autosomal recessive 18 | | | | 27 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TRAPPC11 CL E G H | 60684 | 25751 | ORPHA:369840 | TRAPPC11-related limb-girdle muscular dystrophy R18 | | | | 27 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TRMU CL E G H | 55687 | 25481 | OMIM:613070 | Liver failure, infantile, transient | | | | 101 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 138 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | UBE4B CL E G H | 10277 | 12500 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 63 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | VPS33A CL E G H | 65082 | 18179 | OMIM:617303 | Mucopolysaccharidosis-Plus syndrome | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | VPS4A CL E G H | 27183 | 13488 | OMIM:619273 | CIMDAG SYNDROME; CIMDAG | | | | 1 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:436182 | Microcephalic primordial dwarfism-insulin resistance syndrome | | | | 9 | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | YARS1 CL E G H | 8565 | 12840 | OMIM:619418 | NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2 | | | | | | |
HP:0006561 | HP:0006561 | Lipid accumulation in hepatocytes | 0 | ZPR1 CL E G H | 8882 | 13051 | OMIM:619321 | GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ABCG5 CL E G H | 64240 | 13886 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 67 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ABCG8 CL E G H | 64241 | 13887 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 76 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ABHD5 CL E G H | 51099 | 21396 | OMIM:275630 | Chanarin-Dorfman syndrome | . | | | 90 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ABHD5 CL E G H | 51099 | 21396 | ORPHA:98907 | Neutral lipid storage disease with ichthyosis | HP:0040282 - Frequent | | | 90 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACAD9 CL E G H | 28976 | 21497 | ORPHA:99901 | Acyl-CoA dehydrogenase 9 deficiency | HP:0040282 - Frequent | | | 98 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACAD9 CL E G H | 28976 | 21497 | OMIM:611126 | Mitochondrial complex I deficiency due to acad9 deficiency | | | | 98 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | . | | | 197 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 197 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 90 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ACOX1 CL E G H | 51 | 119 | OMIM:264470 | Peroxisomal acyl-coa oxidase deficiency | | | | 120 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ADK CL E G H | 132 | 257 | OMIM:614300 | Hypermethioninemia due to adenosine kinase deficiency | . | | | 26 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 85 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | AGPAT2 CL E G H | 10555 | 325 | OMIM:608594 | Lipodystrophy, congenital generalized, type 1 | . | | | 85 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | AKR1D1 CL E G H | 6718 | 388 | ORPHA:79303 | Congenital bile acid synthesis defect type 2 | | | | 62 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | AKT2 CL E G H | 208 | 392 | ORPHA:79085 | AKT2-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 12 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | . | | | 73 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | HP:0040283 - Occasional | | | 404 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | . | | | 404 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | APOB CL E G H | 338 | 603 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 356 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | HP:0040282 - Frequent | | | 39 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ATP6AP1 CL E G H | 537 | 868 | OMIM:300972 | IMMUNODEFICIENCY 47; IMD47 | | | | 5 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ATP6AP2 CL E G H | 10159 | 18305 | OMIM:301045 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R | | | | 36 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | HP:0040281 - Very frequent | | | 315 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BCS1L CL E G H | 617 | 1020 | ORPHA:53693 | GRACILE syndrome | HP:0040281 - Very frequent | | | 72 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | | | | 72 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 105 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | . | | | 105 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | HP:0040282 - Frequent | | | 105 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CARS2 CL E G H | 79587 | 25695 | OMIM:616672 | Combined oxidative phosphorylation deficiency 27 | | | | 35 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CASZ1 CL E G H | 54897 | 26002 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 11 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CAV1 CL E G H | 857 | 1527 | OMIM:612526 | Lipodystrophy, congenital generalized, type 3 | | | | 11 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 48 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CAVIN1 CL E G H | 284119 | 9688 | OMIM:613327 | Lipodystrophy, congenital generalized, type 4 | . | | | 48 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CBS CL E G H | 875 | 1550 | OMIM:236200 | Homocystinuria due to cystathionine beta-synthase deficiency | . | | | 242 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CEP19 CL E G H | 84984 | 28209 | OMIM:615703 | Morbid obesity and spermatogenic failure | | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CIDEC CL E G H | 63924 | 24229 | ORPHA:435651 | CIDEC-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 8 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CIDEC CL E G H | 63924 | 24229 | OMIM:615238 | Lipodystrophy, familial partial, type 5 | . | | | 8 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CLPB CL E G H | 81570 | 30664 | ORPHA:445038 | 3-methylglutaconic aciduria type 7 | HP:0040283 - Occasional | | | 38 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CLPB CL E G H | 81570 | 30664 | OMIM:616271 | 3-Methylglutaconic aciduria with cataracts, neurologic involvement, and neutropenia | | | | 38 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | COX15 CL E G H | 1355 | 2263 | OMIM:615119 | Mitochondrial complex IV deficiency, nuclear type 6 | . | | | 104 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CPT1A CL E G H | 1374 | 2328 | OMIM:255120 | Carnitine palmitoyltransferase I deficiency | . | | | 99 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040283 - Occasional | | | 101 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228305 | Carnitine palmitoyl transferase II deficiency, severe infantile form | HP:0040283 - Occasional | | | 101 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:600649 | Carnitine palmitoyltransferase II deficiency, infantile | | | | 101 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CYP19A1 CL E G H | 1588 | 2594 | ORPHA:91 | Aromatase deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | HP:0040281 - Very frequent | | | 11 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DDOST CL E G H | 1650 | 2728 | ORPHA:300536 | DDOST-CDG | HP:0040281 - Very frequent | | | 62 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DEF6 CL E G H | 50619 | 2760 | OMIM:619573 | IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87 | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DGUOK CL E G H | 1716 | 2858 | OMIM:251880 | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | . | | | 57 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DHCR7 CL E G H | 1717 | 2860 | OMIM:270400 | Smith-Lemli-Opitz syndrome | | | | 159 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DNAJC19 CL E G H | 131118 | 30528 | OMIM:610198 | 3-@methylglutaconic aciduria, type V | | | | 25 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DNAJC19 CL E G H | 131118 | 30528 | ORPHA:66634 | Dilated cardiomyopathy with ataxia | | | | 25 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DOCK2 CL E G H | 1794 | 2988 | OMIM:616433 | Immunodeficiency 40 | | | | 6 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | DPM1 CL E G H | 8813 | 3005 | ORPHA:79322 | DPM1-CDG | HP:0040283 - Occasional | | | 27 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | EARS2 CL E G H | 124454 | 29419 | OMIM:614924 | Combined oxidative phosphorylation deficiency 12 | | | | 80 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ETFA CL E G H | 2108 | 3481 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 37 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ETFB CL E G H | 2109 | 3482 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 27 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ETFDH CL E G H | 2110 | 3483 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 77 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | FARSA CL E G H | 2193 | 3592 | OMIM:619013 | RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2 | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | FARSB CL E G H | 10056 | 17800 | OMIM:613658 | Rajab interstitial lung disease with brain calcifications | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040283 - Occasional | | | 64 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | GABRD CL E G H | 2563 | 4084 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | GPD1 CL E G H | 2819 | 4455 | OMIM:614480 | Hypertriglyceridemia, transient infantile | . | | | 3 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HADH CL E G H | 3033 | 4799 | OMIM:231530 | 3-Hydroxyacyl-Coa dehydrogenase deficiency | . | | | 41 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040281 - Very frequent | | | 41 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HNF1B CL E G H | 6928 | 11630 | ORPHA:93111 | HNF1B-related autosomal dominant tubulointerstitial kidney disease | HP:0040283 - Occasional | | | 90 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HNRNPA1 CL E G H | 3178 | 5031 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040283 - Occasional | | | 31 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HNRNPA2B1 CL E G H | 3181 | 5033 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040283 - Occasional | | | 5 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HSD17B4 CL E G H | 3295 | 5213 | OMIM:261515 | D-bifunctional protein deficiency | | | | 98 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 345 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | IARS1 CL E G H | 3376 | 5330 | ORPHA:541423 | Growth delay-intellectual disability-hepatopathy syndrome | HP:0040282 - Frequent | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | IARS1 CL E G H | 3376 | 5330 | OMIM:617093 | Growth retardation, impaired intellectual development, hypotonia, and hepatopathy | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | IFIH1 CL E G H | 64135 | 18873 | OMIM:615846 | Aicardi-Goutieres syndrome 7 | | | | 28 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | KCNAB2 CL E G H | 8514 | 6229 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | KMT2B CL E G H | 9757 | 15840 | OMIM:619934 | | | | | 11 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LARS1 CL E G H | 51520 | 6512 | OMIM:615438 | Infantile liver failure syndrome 1 | . | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LDLR CL E G H | 3949 | 6547 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 2157 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LDLRAP1 CL E G H | 26119 | 18640 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 73 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LIPA CL E G H | 3988 | 6617 | OMIM:278000 | Lysosomal acid lipase deficiency | | | | 73 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LIPE CL E G H | 3991 | 6621 | ORPHA:435660 | LIPE-related familial partial lipodystrophy | HP:0040281 - Very frequent | | | 7 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LIPE CL E G H | 3991 | 6621 | OMIM:615980 | Lipodystrophy, familial partial, type 6 | . | | | 7 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | HP:0040281 - Very frequent | | | 645 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:280365 | Autosomal semi-dominant severe lipodystrophic laminopathy | HP:0040282 - Frequent | | | 645 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:2348 | Familial partial lipodystrophy, Dunnigan type | HP:0040283 - Occasional | | | 645 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:79084 | Familial partial lipodystrophy, Köbberling type | HP:0040282 - Frequent | | | 645 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNA CL E G H | 4000 | 6636 | OMIM:151660 | Lipodystrophy, familial partial, type 2 | . | | | 645 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LMNB2 CL E G H | 84823 | 6638 | ORPHA:79087 | Acquired partial lipodystrophy | HP:0040283 - Occasional | | | 11 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | HP:0040282 - Frequent | | | 191 | | |
HP:0006561 | HP:0006565 | Increased hepatocellular lipid droplets | 1 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | . | | | 191 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | | | | 191 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LUZP1 CL E G H | 7798 | 14985 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | . | | | 4 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MARS1 CL E G H | 4141 | 6898 | OMIM:615486 | Interstitial lung and liver disease | . | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | | | | 81 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MICOS13 CL E G H | 125988 | 33702 | OMIM:618329 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37 | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MMP23B CL E G H | 8510 | 7171 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MPV17 CL E G H | 4358 | 7224 | OMIM:618400 | Charcot-Marie-Tooth disease, axonal, type 2EE | | | | 56 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MPV17 CL E G H | 4358 | 7224 | OMIM:256810 | Navajo neurohepatopathy | | | | 56 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MRPL3 CL E G H | 11222 | 10379 | OMIM:614582 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9 | | | | 13 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MRPL44 CL E G H | 65080 | 16650 | OMIM:615395 | Combined oxidative phosphorylation deficiency 16 | | | | 13 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MRPS7 CL E G H | 51081 | 14499 | OMIM:617872 | Combined oxidative phosphorylation deficiency 34 | . | | | 12 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MTTP CL E G H | 4547 | 7467 | ORPHA:14 | Abetalipoproteinemia | HP:0040283 - Occasional | | | 81 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | MTX2 CL E G H | 10651 | 7506 | OMIM:619127 | MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NDUFAF1 CL E G H | 51103 | 18828 | OMIM:618234 | Mitochondrial complex I deficiency, nuclear type 11 | | | | 40 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NFS1 CL E G H | 9054 | 15910 | OMIM:619386 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52 | | | | 5 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | | | | 32 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NHLRC2 CL E G H | 374354 | 24731 | OMIM:618278 | Fibrosis, neurodegeneration, and cerebral angiomatosis | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NSMCE2 CL E G H | 286053 | 26513 | ORPHA:436182 | Microcephalic primordial dwarfism-insulin resistance syndrome | HP:0040281 - Very frequent | | | 2 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PCK1 CL E G H | 5105 | 8724 | OMIM:261680 | Phosphoenolpyruvate carboxykinase deficiency, cytosolic | . | | | 53 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PCK2 CL E G H | 5106 | 8725 | OMIM:261650 | Phosphoenolpyruvate carboxykinase 2, mitochondrial | . | | | 6 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PCSK9 CL E G H | 255738 | 20001 | ORPHA:391665 | Homozygous familial hypercholesterolemia | HP:0040282 - Frequent | | | 178 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PDPN CL E G H | 10630 | 29602 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PGM1 CL E G H | 5236 | 8905 | OMIM:614921 | Congenital disorder of glycosylation, type It | | | | 58 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PHKA2 CL E G H | 5256 | 8926 | ORPHA:264580 | Glycogen storage disease due to liver phosphorylase kinase deficiency | HP:0040283 - Occasional | | | 54 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PHKG2 CL E G H | 5261 | 8931 | ORPHA:264580 | Glycogen storage disease due to liver phosphorylase kinase deficiency | HP:0040283 - Occasional | | | 48 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PIGA CL E G H | 5277 | 8957 | OMIM:300868 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | | | | 46 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PLIN1 CL E G H | 5346 | 9076 | OMIM:613877 | Lipodystrophy, familial partial, type 4 | . | | | 19 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PLIN1 CL E G H | 5346 | 9076 | ORPHA:280356 | PLIN1-related familial partial lipodystrophy | HP:0040280 - Obligate | | | 19 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PMM2 CL E G H | 5373 | 9115 | OMIM:212065 | Congenital disorder of glycosylation, type Ia | . | | | 150 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PNPLA2 CL E G H | 57104 | 30802 | OMIM:610717 | Neutral lipid storage disease with myopathy | . | | | 65 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PNPLA2 CL E G H | 57104 | 30802 | ORPHA:98908 | Neutral lipid storage myopathy | HP:0040282 - Frequent | | | 65 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | POLD1 CL E G H | 5424 | 9175 | OMIM:615381 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | . | | | 731 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | | | | 464 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 464 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | HP:0040282 - Frequent | | | 138 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | . | | | 42 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PRDM16 CL E G H | 63976 | 14000 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 148 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PRKCZ CL E G H | 5590 | 9412 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | PTRH2 CL E G H | 51651 | 24265 | OMIM:616263 | Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset | . | | | 6 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | RERE CL E G H | 473 | 9965 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 16 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | RINT1 CL E G H | 60561 | 21876 | OMIM:618641 | INFANTILE LIVER FAILURE SYNDROME 3; ILFS3 | | | | 99 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | . | | | 26 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | RNU7-1 CL E G H | 100147744 | 34033 | OMIM:619487 | AICARDI-GOUTIERES SYNDROME 9; AGS9 | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 125 | | |
HP:0006561 | HP:0006565 | Increased hepatocellular lipid droplets | 1 | SAR1B CL E G H | 51128 | 10535 | ORPHA:71 | Chylomicron retention disease | HP:0040282 - Frequent | | | 8 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SAR1B CL E G H | 51128 | 10535 | ORPHA:71 | Chylomicron retention disease | HP:0040283 - Occasional | | | 8 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SCO1 CL E G H | 6341 | 10603 | OMIM:619048 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4 | | | | 46 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SKI CL E G H | 6497 | 10896 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 150 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040281 - Very frequent | | | 82 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC25A13 CL E G H | 10165 | 10983 | OMIM:603471 | Citrullinemia, type II, adult-onset | . | | | 82 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247598 | Neonatal intrahepatic cholestasis due to citrin deficiency | HP:0040282 - Frequent | | | 82 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC25A20 CL E G H | 788 | 1421 | OMIM:212138 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:619525 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw; CDG2W | | | | 110 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040282 - Frequent | | | 110 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC40A1 CL E G H | 30061 | 10909 | ORPHA:139491 | Hemochromatosis type 4 | HP:0040282 - Frequent | | | 56 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SLC40A1 CL E G H | 30061 | 10909 | OMIM:606069 | Hemochromatosis, type 4 | | | | 56 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SPEN CL E G H | 23013 | 17575 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SPTBN1 CL E G H | 6711 | 11275 | OMIM:619475 | DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | SUCLG1 CL E G H | 8802 | 11449 | ORPHA:17 | Fatal infantile lactic acidosis with methylmalonic aciduria | HP:0040282 - Frequent | | | 60 | | |
HP:0006561 | HP:0006565 | Increased hepatocellular lipid droplets | 1 | SURF1 CL E G H | 6834 | 11474 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | 73 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TARS2 CL E G H | 80222 | 30740 | OMIM:615918 | Combined oxidative phosphorylation deficiency 21 | . | | | 28 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TBX1 CL E G H | 6899 | 11592 | OMIM:188400 | Digeorge syndrome | | | | 32 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TFAM CL E G H | 7019 | 11741 | OMIM:617156 | Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TKFC CL E G H | 26007 | 24552 | OMIM:618805 | TRIOKINASE AND FMN CYCLASE DEFICIENCY SYNDROME; TKFCD | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TMEM199 CL E G H | 147007 | 18085 | OMIM:616829 | Congenital disorder of glycosylation, type IIP | | | | 4 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TRAPPC11 CL E G H | 60684 | 25751 | OMIM:615356 | Muscular dystrophy, limb-girdle, autosomal recessive 18 | HP:0040283 - Occasional | | | 27 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TRAPPC11 CL E G H | 60684 | 25751 | ORPHA:369840 | TRAPPC11-related limb-girdle muscular dystrophy R18 | HP:0040283 - Occasional | | | 27 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TRMU CL E G H | 55687 | 25481 | OMIM:613070 | Liver failure, infantile, transient | | | | 101 | | |
HP:0006561 | HP:0006565 | Increased hepatocellular lipid droplets | 1 | TRNN CL E G H | 4570 | 7493 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | | | |
HP:0006561 | HP:0006565 | Increased hepatocellular lipid droplets | 1 | TRNS1 CL E G H | 4574 | 7497 | OMIM:220110 | Mitochondrial complex IV deficiency | . | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 138 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | UBE4B CL E G H | 10277 | 12500 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040283 - Occasional | | | 63 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | VPS33A CL E G H | 65082 | 18179 | OMIM:617303 | Mucopolysaccharidosis-Plus syndrome | | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | VPS4A CL E G H | 27183 | 13488 | OMIM:619273 | CIMDAG SYNDROME; CIMDAG | | | | 1 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:436182 | Microcephalic primordial dwarfism-insulin resistance syndrome | HP:0040281 - Very frequent | | | 9 | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | YARS1 CL E G H | 8565 | 12840 | OMIM:619418 | NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2 | | | | | | |
HP:0006561 | HP:0001397 | Hepatic steatosis | 1 | ZPR1 CL E G H | 8882 | 13051 | OMIM:619321 | GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF | | | | | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | ACAD9 CL E G H | 28976 | 21497 | OMIM:611126 | Mitochondrial complex I deficiency due to acad9 deficiency | . | | | 98 | | |
HP:0006561 | HP:0006555 | Diffuse hepatic steatosis | 2 | ACOX1 CL E G H | 51 | 119 | OMIM:264470 | Peroxisomal acyl-coa oxidase deficiency | . | | | 120 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | . | | | 72 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | CARS2 CL E G H | 79587 | 25695 | OMIM:616672 | Combined oxidative phosphorylation deficiency 27 | . | | | 35 | | |
HP:0006561 | HP:0006555 | Diffuse hepatic steatosis | 2 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | HP:0040282 - Frequent | | | | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | CPT2 CL E G H | 1376 | 2330 | OMIM:600649 | Carnitine palmitoyltransferase II deficiency, infantile | . | | | 101 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | . | | | 101 | | |
HP:0006561 | HP:0006573 | Acute hepatic steatosis | 2 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | HP:0040281 - Very frequent | | | 11 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | CYP7A1 CL E G H | 1581 | 2651 | ORPHA:209902 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | HP:0040281 - Very frequent | | | 11 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | DNAJC19 CL E G H | 131118 | 30528 | OMIM:610198 | 3-@methylglutaconic aciduria, type V | . | | | 25 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | DNAJC19 CL E G H | 131118 | 30528 | ORPHA:66634 | Dilated cardiomyopathy with ataxia | HP:0040283 - Occasional | | | 25 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | DOCK2 CL E G H | 1794 | 2988 | OMIM:616433 | Immunodeficiency 40 | | | | 6 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | EARS2 CL E G H | 124454 | 29419 | OMIM:614924 | Combined oxidative phosphorylation deficiency 12 | HP:0040283 - Occasional | | | 80 | | |
HP:0006561 | HP:0006555 | Diffuse hepatic steatosis | 2 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040282 - Frequent | | | 99 | | |
HP:0006561 | HP:0006555 | Diffuse hepatic steatosis | 2 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | LRPPRC CL E G H | 10128 | 15714 | OMIM:220111 | Leigh syndrome, french Canadian type | . | | | 191 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | LYRM4 CL E G H | 57128 | 21365 | OMIM:615595 | Combined oxidative phosphorylation deficiency 19 | | | | 4 | | |
HP:0006561 | HP:0006573 | Acute hepatic steatosis | 2 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | . | | | 81 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | MICOS13 CL E G H | 125988 | 33702 | OMIM:618329 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37 | | | | | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | MPV17 CL E G H | 4358 | 7224 | OMIM:256810 | Navajo neurohepatopathy | . | | | 56 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | MPV17 CL E G H | 4358 | 7224 | OMIM:256810 | Navajo neurohepatopathy | . | | | 56 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | MRPL44 CL E G H | 65080 | 16650 | OMIM:615395 | Combined oxidative phosphorylation deficiency 16 | . | | | 13 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | MTX2 CL E G H | 10651 | 7506 | OMIM:619127 | MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS | | | | | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | NDUFAF1 CL E G H | 51103 | 18828 | OMIM:618234 | Mitochondrial complex I deficiency, nuclear type 11 | . | | | 40 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | NGLY1 CL E G H | 55768 | 17646 | ORPHA:404454 | Alacrimia-choreoathetosis-liver dysfunction syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | NHLRC2 CL E G H | 374354 | 24731 | OMIM:618278 | Fibrosis, neurodegeneration, and cerebral angiomatosis | | | | | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | PIGA CL E G H | 5277 | 8957 | OMIM:300868 | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | | | | 46 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | . | | | 464 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040283 - Occasional | | | 464 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040283 - Occasional | | | 125 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | TFAM CL E G H | 7019 | 11741 | OMIM:617156 | Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | . | | | 1 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | TRMU CL E G H | 55687 | 25481 | OMIM:613070 | Liver failure, infantile, transient | . | | | 101 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | TRMU CL E G H | 55687 | 25481 | OMIM:613070 | Liver failure, infantile, transient | . | | | 101 | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040283 - Occasional | | | 138 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0006561 | HP:0001403 | Macrovesicular hepatic steatosis | 2 | VPS33A CL E G H | 65082 | 18179 | OMIM:617303 | Mucopolysaccharidosis-Plus syndrome | | | | 1 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | VPS4A CL E G H | 27183 | 13488 | OMIM:619273 | CIMDAG SYNDROME; CIMDAG | | | | 1 | | |
HP:0006561 | HP:0001414 | Microvesicular hepatic steatosis | 2 | YARS1 CL E G H | 8565 | 12840 | OMIM:619418 | NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2 | | | | | | |